Uploaded May 2020 | Updated September 2026, 2 weeks ago
TEDMED 2020 Hive Innovator: Niamh O'Hara
CEO & Co-Founder, Biotia
----
Biotia leverages Genomics and AI to Provide Diagnostic Insights. Current infectious disease diagnostic tools are failing us. Culturing, the current gold standard and technology from the 1800s, misses many important pathogens and requires many labor intensive tests. Newer PCR-based tests are limited, problematic and don’t provide drug resistance information. The result is high levels of mortality and drug resistance. At Biotia, we fight infectious disease and drug resistance using rapid precision diagnostics. We work with hospitals internationally, leveraging next-generation DNA sequencing, and our artificial intelligence software to guide patient treatment and save lives.
TEDMED 2020 Hive Innovator: Niamh O'Hara
CEO & Co-Founder, Biotia
----
Biotia leverages Genomics and AI to Provide Diagnostic Insights. Current infectious disease diagnostic tools are failing us. Culturing, the current gold standard and technology from the 1800s, misses many important pathogens and requires many labor intensive tests. Newer PCR-based tests are limited, problematic and don’t provide drug resistance information. The result is high levels of mortality and drug resistance. At Biotia, we fight infectious disease and drug resistance using rapid precision diagnostics. We work with hospitals internationally, leveraging next-generation DNA sequencing, and our artificial intelligence software to guide patient treatment and save lives.
